Versant Venture Capital Vi, L.P. Tempest Therapeutics, Inc. (TPST) insider trading activity

Versant Venture Capital Vi, L.P. is of Tempest Therapeutics, Inc.. Currently has a direct ownership of 209,941 shares of TPST, which is worth approximately $304,414. The most recent transaction as insider was on Aug 12, 2024, when has been sold 387,999 shares (Common Stock) at a price of $1.1 per share, resulting in proceeds of $426,798. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 210K

n/a 3M change

n/a 12M change

Total Value Held $304,414

Versant Venture Capital VI, L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Aug 12 2024	SELL Open market or private sale	$426,798 $1.1 p/Share	387,999 Reduced 64.89%	209,941 Common Stock
Aug 08 2024	SELL Open market or private sale	$540,000 $1.35 p/Share	400,000 Reduced 40.08%	597,940 Common Stock

Also insider at

BDTX

Black Diamond Therapeutics, Inc. Healthcare

ALGS

Aligos Therapeutics, Inc. Healthcare

> 10% Shareholder

OYST

Oyster Point Pharma, Inc. Healthcare

> 10% Shareholder

IPSC

Century Therapeutics, Inc. Healthcare

> 10% Shareholder

GLUE

Monte Rosa Therapeutics, Inc. Healthcare

GRPH

Graphite Bio, Inc. Healthcare

CTNM

Contineum Therapeutics, Inc.

> 10% Shareholder

VVC